Investor Sues Drug Maker Over Anemia Treatment Drug Safety, Efficacy Statements

(April 14, 2021, 2:26 PM EDT) -- SAN FRANCISCO — A shareholder sued a biopharmaceutical company and certain of its current and former executive officers in California federal court on April 14, alleging that the defendants issued a...

To view the full article, register now.